drugset / Trial / NCT07301437
RWS of of Liraglutide Alone and in Combination With Orlistat for Weight Loss in Overweight/Obese Patients.
Phase 4
Not yet recruiting
120 enrolled
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
RandomizedParallel-groupOpen-labelTreatment
Summary
To evaluate the differences in weight loss between liraglutide monotherapy and combined with orlistat in overweight/obese patients.
Timeline
- Start
- 2026-05-01
- Primary completion
- 2027-08-31
- Completion
- 2027-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Liraglutide | Peptide | — | — |
| Subject | Orlistat | Small molecule | — | — |
Indications
No indication recorded.